Check how courts have cited this case. Use our free citator for the most current treatment.
No. 9473399
United States Court of Appeals for the Ninth Circuit
Luke Davis v. Laboratory Corporation of America Holdings
No. 9473399 · Decided February 8, 2024
No. 9473399·Ninth Circuit · 2024·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
February 8, 2024
Citation
No. 9473399
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED
UNITED STATES COURT OF APPEALS FEB 8 2024
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
LUKE DAVIS, JULIAN VARGAS, and No. 22-55873
AMERICAN COUNCIL OF THE BLIND,
individually and on behalf of all others D.C. No. 2:20-cv-00893-FMO-KS
similarly situated,
Plaintiff-Appellee, MEMORANDUM*
v.
LABORATORY CORPORATION OF
AMERICA HOLDINGS, d/b/a LABCORP,
Defendant-Appellant.
Appeal from the United States District Court
for the Central District of California
Fernando M. Olguin, District Judge, Presiding
Argued and Submitted November 9, 2023
Pasadena, California
Before: FLETCHER and MENDOZA, Circuit Judges, and SCHREIER, ** District
Judge.
* This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
** The Honorable Karen E. Schreier, United States District Judge for the
District of South Dakota, sitting by designation.
On May 23, 2022, the district court certified two classes in the instant action:
a California class under Federal Rule of Civil Procedure 23(b)(3) seeking damages
under California’s Unruh Civil Rights Act (Unruh Act); and a nationwide class
seeking relief under the Americans with Disabilities Act (ADA), the Rehabilitation
Act, and the Affordable Care Act. On June 13, 2022, the district court amended its
class certification order to refine the class definitions. LabCorp filed an
interlocutory appeal of the May 23 class-certification order under Rule 23(f), sua
sponte challenging plaintiffs’ Article III standing, as well as the propriety of the
district court’s certification order. We authorized the interlocutory appeal on
September 22, 2022. We have jurisdiction under 28 U.S.C. § 1292(e) and Rule
23(f). Considering Article III standing de novo, Crum v. Circus Circus Enters.,
231 F.3d 1129, 1130 (9th Cir. 2000), and reviewing the district court’s class-
certification decision for abuse of discretion, Sali v. Corona Reg’l Med. Ctr., 909
F.3d 996, 1002 (9th Cir. 2018), we affirm.
1. LabCorp argues that plaintiffs lack Article III standing for their Unruh
Act claim because class representative Vargas, along with class members, did not
experience a cognizable injury and were not concretely harmed. Although the
district court did not directly address standing in either of its class-certification
orders, “we have an independent duty to do so before turning to the merits.”
Langer v. Kiser, 57 F.4th 1085, 1091 (9th Cir. 2023). “To establish injury in fact, a
2
plaintiff must show that he or she suffered ‘an invasion of a legally protected
interest’ that is ‘concrete and particularized’ and ‘actual or imminent, not
conjectural or hypothetical.’” Spokeo, Inc. v. Robins, 578 U.S. 330, 338 (2016)
(quoting Lujan v. Defenders of Wildlife, 504 U.S. 555, 560 (1992)). In the
disability discrimination context, we have found that “it is not necessary for
standing purposes that the barrier completely preclude the plaintiff from entering
or from using a facility in any way.” Chapman v. Pier 1 Imports (U.S.) Inc., 631
F.3d 939, 947 (9th Cir. 2011). Instead, the plaintiff need only demonstrate that the
barrier “interfere[s] with the plaintiff’s ‘full and equal enjoyment’ of the facility.”
Id. (quoting 42 U.S.C. § 12182). Full and equal enjoyment requires “effective
communication” with disabled individuals. Robles v. Domino’s Pizza, LLC, 913
F.3d 898, 906-07 (9th Cir. 2019); see also 28 C.F.R. § 36.303(c)(1).
Vargas established an injury sufficient to confer standing. Because a
plaintiff must demonstrate standing “with the manner and degree of evidence
required at the successive stages of the litigation,” Lujan, 504 U.S. at 561 (1992),
we assess whether plaintiffs have demonstrated standing under a “preponderance
of the evidence” standard, Olean Wholesale Grocery Coop., Inc. v. Bumble Bee
Foods LLC, 31 F.4th 651, 665 (9th Cir. 2022). Vargas contends that he entered a
LabCorp facility and intended to check in using the kiosk but was unable to do so
because the kiosk was not accessible to the blind. Instead, Vargas was forced to
3
wait until he was noticed by a staff member who aided him with check-in. As a
result of the inaccessibility of the kiosk, Vargas was unable to immediately
preserve his place in the patient queue, as sighted patients could, or to access any
other kiosk features, such as the ability to privately alter account information.
Thus, Vargas was denied effective communication and, by extension, the full and
equal enjoyment of LabCorp’s services. This injury is adequately concrete to
convey Article III standing.
2. The district court also did not abuse its discretion in certifying the
Unruh Act class over LabCorp’s objections to commonality, predominance,
typicality, manageability, and superiority. To certify a class under Rule 23,
plaintiffs must make two showings. First, plaintiffs must demonstrate
commonality, numerosity, typicality, and adequacy of representation under Rule
23(a). “Second, the plaintiffs must show that the class fits into one of three
categories.” Olean Wholesale Grocery Coop., 31 F.4th at 663. This case falls into
the third category, which permits a class action if “questions of law or fact
common to class members predominate over any questions affecting only
individual members, and that a class action is superior to other available methods
for fairly and efficiently adjudicating the controversy.” Fed. R. Civ. P. 23(b)(3).
LabCorp first challenges the district court’s finding that common facts
predominate the Unruh Act claim, arguing that the standing of each class member
4
requires “an individualized inquiry” into whether each class member has
demonstrated “difficulty, discomfort, or embarrassment.” But difficulty,
discomfort, or embarrassment are required to recover damages only in
construction-related Unruh Act claims. See Cal. Civ. Code § 55.56(c). Because
this case concerns effective communication and not construction, such a showing
for each plaintiff is not required. Nor is it required that each plaintiff suffer
identical harm; rather, the relevant inquiry is whether class members were subject
to the same injuring behavior. See Just Film, Inc. v. Buono, 847 F.3d 1108, 1120
(9th Cir. 2017). Because all class members maintain that their injury resulted from
the inaccessibility of a LabCorp kiosk, the commonality requirement is satisfied. 1
Based on the same findings, we also uphold the district court’s holding that
common questions predominate. The district court identified six common issues,
whose answers could determine key elements of the case. Finding that these
questions predominate is not an abuse of the district court’s discretion.
Next, LabCorp challenges the typicality of Vargas’s claim, arguing that his
experiences and the experiences of class members “varied significantly.” Rule 23’s
typicality requirement, however, is a “permissive standard,” satisfied when
1 LabCorp’s allegation that some potential class members may not have been
injured does not defeat commonality at this time. See Olean, 31 F.4th at 668–69
(holding that Rule 23 permits “certification of a class that potentially includes
more than a de minimus number of uninjured class members”).
5
representative claims “are reasonably co-extensive with those of absent class
members[.]” Castillo v. Bank of Am., NA, 980 F.3d 723, 729 (9th Cir. 2020)
(quotations omitted). Representative claims “need not be substantially identical[]”
to the claims of absent members. Id. Here, like the absent class members, Vargas
is blind, tried to access LabCorp services, and was unable to do so using a kiosk.
Thus, his claim is typical of the class, and the district court did not abuse its
discretion in so finding.
Lastly, LabCorp challenges the superiority of class adjudication, as required
by Rule 23(b)(3). Though four factors determine superiority under the Rule,
LabCorp disputes only the fourth factor: the manageability of the class. Fed. R.
Civ. P. 23(b)(3)(A)–(D). LabCorp contends that the class is unmanageable because
there is no proposed way of identifying which persons visiting LabCorp stations
are legally blind.2
As the district court found, “identifying class members would not be
difficult” because “Labcorp knows how many patients checked in, and has
2 Though LabCorp also argues that the $4,000 damages amount available under the
Unruh Act is significant enough to weigh against superiority under Rule 23(b)(3),
such concerns are typically adjudicated under the Rule 23(a) factors. But, even if
we were to consider LabCorp’s argument, we agree with the district court that the
$4,000 statutory damage amount is a minimal sum that “would be dwarfed by the
cost of litigating on an individual basis” in this case, given the complexity of the
litigation. See Wolin v. Jaguar Land Rover N. Am., LLC, 617 F.3d 1168, 1175 (9th
Cir. 2010).
6
information on those patients from their provided ID and insurance.” Though no
specific method for identifying class members has been identified, claims
administrators, auditing processes, and other techniques may be used to validate
claims. And as the court managing the litigation process, the district court is best
situated to determine its own capacity to oversee the location of class members.
3. The district court did not abuse its discretion in certifying the
nationwide class based on its determination that a nationwide injunction could
provide relief to all members. The district court certified the nationwide class
under Rule 23(b)(2), which permits class certification when “the party opposing
the class has acted or refused to act on grounds that apply generally to the class, so
that final injunctive relief . . . is appropriate respecting the class as a whole[.]”
LabCorp argues that no single injunction could provide relief to all class members,
because not all blind people prefer the same accommodations. But the class
members in this action were not injured by LabCorp’s failure to meet their
preferences; instead, all class members were injured by the complete
inaccessibility of LabCorp kiosks for blind individuals. As the district court
reasoned, by adding technological accommodations, the kiosks could be rendered
accessible to the blind, thus addressing the injuries of the entire class. Although
some class members may still prefer not to use the kiosks, providing them the
7
ability to make that choice in the first place relieves any current injury. The district
court did not abuse its discretion in reaching the same conclusion.
4. Lastly, we decline to address LabCorp’s argument that the district
court erred in certifying two fail-safe classes. LabCorp appeals only the district
court’s May 23 order, and not the revised class definitions in its June 13 order.
Although LabCorp’s argument references the refined definitions from the June 13
order, only the May 23 order was attached to LabCorp’s interlocutory appeal, as is
required by Federal Rule of Appellate Procedure 5. Further, LabCorp never
attempted to amend or refile its interlocutory appeal to include the June 13 order.
Therefore, LabCorp’s argument is not properly before this court. See Stockwell v.
City and County of San Francisco, 749 F.3d 1107, 1113 (9th Cir. 2014) (“We must
police the bounds of our jurisdiction vigorously [concerning Rule 23(f) appeals] as
elsewhere.”)
AFFIRMED.
8
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 8 2024 MOLLY C.
Key Points
01NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 8 2024 MOLLY C.
02COURT OF APPEALS FOR THE NINTH CIRCUIT LUKE DAVIS, JULIAN VARGAS, and No.
0322-55873 AMERICAN COUNCIL OF THE BLIND, individually and on behalf of all others D.C.
042:20-cv-00893-FMO-KS similarly situated, Plaintiff-Appellee, MEMORANDUM* v.
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 8 2024 MOLLY C.
FlawCheck shows no negative treatment for Luke Davis v. Laboratory Corporation of America Holdings in the current circuit citation data.
This case was decided on February 8, 2024.
Use the citation No. 9473399 and verify it against the official reporter before filing.